Aadi Bioscience (NASDAQ:AADI) reported its Q1 earnings results on Wednesday, May 10, 2023 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Aadi Bioscience beat estimated earnings by 1.72%, reporting an EPS of $-0.57 versus an estimate of $-0.58.
Revenue was up $3.56 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.19 which was followed by a 3.94% increase in the share price the next day.
Here’s a look at Aadi Bioscience’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.71 | -0.74 | -0.75 | -0.71 |
| EPS Actual | -0.52 | -0.68 | -0.69 | -0.66 |
| Revenue Estimate | 4.65M | 3.77M | 2.75M | 500K |
| Revenue Actual | 5.23M | 4.25M | 3.44M | 2.31M |
To track all earnings releases for Aadi Bioscience visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
